An N-propargyl pyrroloimidazolone with syn stereochemistry derived from L-proline serves as a starting material for the diastereoselective synthesis (> 95:5 dr) of propargyl alkynes or allenamides by direct quench of its lithiated intermediate with alkylating agents or aldehydes/ketones, respectively. Use of the epimeric anti pyrroloimidazolone starting material results in reversal of stereochemistry at the propargyl position in the products, without the need to prepare a separate substrate from D-proline. Lithiation of the syn pyrroloimidazolone and quench with prochiral benzaldehydes without prior transmetalation gives allenamides with crystallographically verified atypical stereochemistry of the benzylic alcohol in > 95:5 dr. The epimeric series of benzylic alcohols may also be obtained in > 95:5 dr by employing transmetalation with chlorotitanium triisopropoxide prior to aldehyde quench. Density Functional Theory (DFT) computational studies provide a rationale for the change in benzylic alcohol stereochemistry by virtue of differing stereofacial attack in 6,5-bicyclic (Li) or 6-membered (Ti) transition states.
A variety of enantiomerically enriched tetrahydrofuran spirocyclic derivatives have been synthesised by a sequential enantioselective proline‐induced stereospecific resolution through aldol reaction of (E/Z)‐(phenylsulfanyl)cycloalkanecarbaldehydes followed by a ketone reduction, acid‐catalysed [1,2]‐SPh stereospecific migration, and ring‐closure reaction.
The reaction between configurably stable -lithiated oxiranes (and aziridines) and 3-substituted cyclobutanones allows to obtain enantiomerically enriched cyclobutanols (er > 98:2). These adducts, subjected to base-mediated Payne rearrangement lead to...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.